citalopram	metoprolol	1	1	true	positive	Administration of 40 mg/day citalopram for 22 days resulted in a two-fold increase in the plasma levels of the beta-adrenergic blocker metoprolol.  		2556	6918	2556	D008790
citalopram	metoprolol	1	1	true	positive	Administration of 40 mg/day citalopram for 22 days resulted in a two-fold increase in the plasma levels of the beta-adrenergic blocker metoprolol.  		2556	6918	2556	D008790
citalopram	metoprolol	1	2	true	positive	Administration of 40 mg/day citalopram for 22 days resulted in a two-fold increase in the plasma levels of the beta-adrenergic blocker metoprolol.  Increased metoprolol plasma levels have been associated with decreased cardioselectivity.  		2556	6918	2556	D008790
citalopram	metoprolol	1	2	true	positive	Administration of 40 mg/day citalopram for 22 days resulted in a two-fold increase in the plasma levels of the beta-adrenergic blocker metoprolol.  Increased metoprolol plasma levels have been associated with decreased cardioselectivity.  		2556	6918	2556	D008790
citalopram	metoprolol	1	3	true	positive	Administration of 40 mg/day citalopram for 22 days resulted in a two-fold increase in the plasma levels of the beta-adrenergic blocker metoprolol.  Increased metoprolol plasma levels have been associated with decreased cardioselectivity.  Coadministration of citalopram and metoprolol had no clinically significant effects on blood pressure or heart rate.  		2556	6918	2556	D008790
citalopram	metoprolol	1	3	true	positive	Administration of 40 mg/day citalopram for 22 days resulted in a two-fold increase in the plasma levels of the beta-adrenergic blocker metoprolol.  Increased metoprolol plasma levels have been associated with decreased cardioselectivity.  Coadministration of citalopram and metoprolol had no clinically significant effects on blood pressure or heart rate.  		2556	6918	2556	D008790
citalopram	metoprolol	3	1	true	positive	Administration of 40 mg/day citalopram for 22 days resulted in a two-fold increase in the plasma levels of the beta-adrenergic blocker metoprolol.  Increased metoprolol plasma levels have been associated with decreased cardioselectivity.  Coadministration of citalopram and metoprolol had no clinically significant effects on blood pressure or heart rate.  		2556	6918	2556	D008790
citalopram	metoprolol	3	1	true	positive	Administration of 40 mg/day citalopram for 22 days resulted in a two-fold increase in the plasma levels of the beta-adrenergic blocker metoprolol.  Increased metoprolol plasma levels have been associated with decreased cardioselectivity.  Coadministration of citalopram and metoprolol had no clinically significant effects on blood pressure or heart rate.  		2556	6918	2556	D008790
citalopram	metoprolol	3	2	false	none	Increased metoprolol plasma levels have been associated with decreased cardioselectivity.  Coadministration of citalopram and metoprolol had no clinically significant effects on blood pressure or heart rate.  		2556	6918	2556	D008790
citalopram	metoprolol	3	2	false	none	Increased metoprolol plasma levels have been associated with decreased cardioselectivity.  Coadministration of citalopram and metoprolol had no clinically significant effects on blood pressure or heart rate.  		2556	6918	2556	D008790
citalopram	metoprolol	3	3	false	none	Coadministration of citalopram and metoprolol had no clinically significant effects on blood pressure or heart rate.  		2556	6918	2556	D008790
citalopram	metoprolol	3	3	false	none	Coadministration of citalopram and metoprolol had no clinically significant effects on blood pressure or heart rate.  		2556	6918	2556	D008790
